A healthcare software solution to improve follow-up care of patients

October 01, 2003

Monitoring patients once they have left hospital is a vital part of follow-up care, but many small clinics and hospitals find it difficult to provide.

EUREKA's MADISON project has developed a new computer package which will give small institutions the technical means to improve follow-up of outpatients by accessing the servers of larger hospitals. Using the new software, they can access and use the data held in the larger institutions to better follow patients' medical and nutritional care and to set up automated prescription services.

The project focused in particular on nutritional follow-up, so the software could be used to monitor diabetes in children or other illnesses where diet is all-important. This could, for example, help to reduce the long term complications caused by diabetes such as damage to the eyes, nerves and kidneys.

"Nutrition is of critical importance for certain patients," says Bernard d'Oriano, Managing Director of Fichier Selection Informatique, the French company leading the project. This is increasingly the case given Europe's ageing population.

"Elderly people can become malnourished very quickly, even if they are still eating and can become critically ill within the space of three weeks." This is a common problem, but one that requires hospitalisation, a costly process that can take weeks. Using this new computing tool, the patient's doctor could alert the hospital when they think the patient is in danger and the hospital could help to monitor the patient's diet.

The MADISON project also developed a new software package that allows doctors to send prescription orders electronically. "The doctor at the patient's bedside enters the prescription onto a laptop or a PDA (Personal Digital Assistant) and sends it via the Internet directly to the hospital's in-house pharmacy," explains Philippe Corteil, Managing Director of the Belgian partner, Medical Business Channel.

The pharmacy can then instantly dispense the medicine and keep an accurate account of both what is going to the patient and the stock available in the pharmacy. At the same time, it enables the prescribing doctor to see what other medicines have been prescribed for the patient and to be alerted if there is a potential clash of medicines.

For d'Oriano, being part of a EUREKA project was advantageous in several ways. "Above all, it brought me the means - a loan, as well as a Belgian technical partner with whom we were able to work, and a certain reputation and recognition," he says.
-end-
EUREKA is ...
A European network for market-oriented R&D
- strengthening European competitiveness
- promoting innovation in market-oriented collaborative projects
- involving industry, research institutes and universities across Europe
- resulting in innovative products, processes and services.

EUREKA

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.